Your Cart ( 1 Item )

• Clinical Profile of Halobetasol Propionate 0.01%/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis
  June 2025 | Volume 24 | Issue 6 | Original Article | 590 | Copyright © June 2025
  Emil Tanghetti MD^a, Linda Stein Gold MD^b, Edward Lain MD^c, Abby Abby PA-C^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs